Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Curr Med Sci. 2021 Oct;41(5):1029-1036. doi: 10.1007/s11596-021-2436-9. Epub 2021 Sep 20.
Autosomal dominant polycystic kidney disease (ADPKD) is mainly caused by the pathogenic mutation of PKD1 or PKD2 gene and usually affects bilateral kidneys. Synonymous mutations are generally assumed to be neutral as they do not alter amino acids. Herein, we described an extremely rare ADPKD child caused by a heterozygous synonymous mutation of PKD2 gene accompanied by massive proteinuria and congenital solitary kidney.
Clinical characteristics of the patients were summarized. Whole-exome sequencing was performed to screen the disease-causing gene mutation, and reverse transcription polymerase chain reaction (RT-PCR) and Sanger sequencing were applied to analyze the impact of the identified mutation on gene transcription and splicing.
Polycystic changes were found in the solitary kidney of a girl initially presented with nephrotic-range proteinuria. Thereafter her mother and 2 other family members were diagnosed to be ADPKD. Whole-exome sequencing of the proband identified a heterozygous synonymous mutation (c.1716G>A, p.Lys572=) located in the splicing site of exon 7 in PKD2 gene, which was co-segregated with the PKD phenotype in the family. RT-PCR and direct sequencing of amplified products revealed that this heterozygous synonymous mutation led to exon7 skipping in PKD2 gene.
We reported an extremely rare child case of ADPKD2 in combination with solitary kidney and nephrotic-range proteinuria, and firstly confirmed the pathogenicity of a heterozygous synonymous mutation (c.1716G>A) in PKD2 gene. The results indicate that synonymous mutations should not be excluded from disease-causing if they are located in splicing site of an exon.
常染色体显性多囊肾病(ADPKD)主要由 PKD1 或 PKD2 基因突变引起,通常影响双侧肾脏。同义突变通常被认为是中性的,因为它们不会改变氨基酸。本文报道了一例极为罕见的 ADPKD 患儿,其由 PKD2 基因杂合同义突变引起,伴有大量蛋白尿和先天性孤立肾。
总结患者的临床特征。进行外显子组测序以筛选致病基因突变,并应用逆转录聚合酶链反应(RT-PCR)和 Sanger 测序分析鉴定突变对基因转录和剪接的影响。
首先表现为肾病范围蛋白尿的女孩的孤立肾中发现多囊性改变。随后,其母亲和另外 2 名家庭成员被诊断为 ADPKD。对先证者进行外显子组测序发现 PKD2 基因exon7 剪接位点存在杂合同义突变(c.1716G>A,p.Lys572=),该突变与家系中的 ADPKD 表型共分离。RT-PCR 和扩增产物的直接测序显示,该杂合同义突变导致 PKD2 基因exon7 缺失。
我们报道了一例极为罕见的 PKD2 合并孤立肾和肾病范围蛋白尿的 ADPKD2 患儿病例,并首次证实了 PKD2 基因exon7 剪接位点杂合同义突变(c.1716G>A)的致病性。结果表明,如果同义突变位于外显子的剪接位点,不应排除其致病可能性。